TickerFacts.

Company research / TRLV

Trulieve Cannabis Corp. (TRLV)

Build a valuation ↗↓ Download CSV

CIK 0001754195 · NYSE · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Trulieve Cannabis Corp. reported revenue of $1.18B. Revenue fell 0.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.14B.

Key ratios (year ended 2025-12-31)

60.2%
Gross margin
12.1%
Operating margin
-10.3%
Net margin
-10.7%
Return on year-end equity
-0.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-08-11

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$1.14B$1.18B$1.19B$1.13B$1.22B$931.93M$521.53M$252.82M
Cost of Revenue$461.65M$470.01M$470.75M$540.57M$529.10M$365.36M$135.12M$60.98M
Gross Profit$677.39M$711.17M$715.75M$588.63M$689.13M$566.57M$386.42M$191.84M
Operating Income-$277.26M$143.50M$97.78M-$221.61M$50.16M$204.05M$218.30M$113.27M
Depreciation & Amortization$114.34M$117.63M$112.81M$109.83M$116.38M$45.79M$12.60M$5.08M
EBITDA-$162.92M$261.13M$210.59M-$111.79M$166.55M$249.84M$230.90M$118.35M
Net Income-$476.16M-$122.25M-$160.58M-$533.14M-$252.73M$17.45M$63.00M$53.09M
EPS (Diluted)n/a-$0.58-$0.79-$2.28-$0.95$0.21$0.53$0.46
Total Assets$2.08B$2.70B$2.87B$2.73B$3.40B$3.41B$809.78Mn/a
Total Liabilities$1.31B$1.55B$1.62B$1.32B$1.47B$1.26B$361.87Mn/a
Long-Term Debt$195.82M$136.74M$364.84M$363.21M$541.66M$462.93Mn/an/a
Shareholders' Equity$765.91M$1.14B$1.25B$1.41B$1.93B$2.15B$447.90M$132.88M
Cash & Equivalents$325.42M$255.53M$238.80M$201.37M$207.19M$226.63M$146.71Mn/a
Operating Cash Flown/a$272.82M$271.48M$201.84M$23.10M$12.90M$99.64M$19.07M
Capital Expendituresn/a$44.19M$122.60M$40.24M$164.75M$275.90M$99.94M$71.83M
Free Cash Flown/a$228.63M$148.88M$161.60M-$141.65M-$263.00M-$298.0K-$52.76M
Shares Outstanding192.38M192.31M191.01M186.24M185.99M180.50M119.57Mn/a
Weighted Average Diluted Sharesn/a191.32M189.99M188.97M188.00M146.76M118.33M115.32M
EPS (Basic)n/a-$0.58-$0.79-$2.28-$0.95$0.22$0.55$0.48

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView